392 related articles for article (PubMed ID: 29474196)
1. Adenocarcinoma Prostate With Neuroendocrine Differentiation: Potential Utility of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT Over 68Ga-PSMA PET/CT.
Parida GK; Tripathy S; Datta Gupta S; Singhal A; Kumar R; Bal C; Shamim SA
Clin Nucl Med; 2018 Apr; 43(4):248-249. PubMed ID: 29474196
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor.
Acar E; Kaya GÇ
Clin Nucl Med; 2019 Jan; 44(1):53-54. PubMed ID: 30325820
[TBL] [Abstract][Full Text] [Related]
3. 68Ga-DOTATOC and 68Ga-PSMA PET/CT Unmasked a Case of Prostate Cancer With Neuroendocrine Differentiation.
Chen S; Cheung SK; Wong KN; Wong KK; Ho CL
Clin Nucl Med; 2016 Dec; 41(12):959-960. PubMed ID: 27764046
[TBL] [Abstract][Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
5. Molecular Imaging in Neuroendocrine Differentiation of Prostate Cancer: 68Ga-PSMA Versus 68Ga-DOTA NOC PET-CT.
Usmani S; Ahmed N; Marafi F; Rasheed R; Amanguno HG; Al Kandari F
Clin Nucl Med; 2017 May; 42(5):410-413. PubMed ID: 28240661
[TBL] [Abstract][Full Text] [Related]
6. Small Cell Transformation of Metastatic Prostate Adenocarcinoma Diagnosed by Dual-Tracer PET/CT (
Parghane R; Basu S
J Nucl Med Technol; 2019 Mar; 47(1):85-87. PubMed ID: 30139889
[TBL] [Abstract][Full Text] [Related]
7. Comparing the Staging/Restaging Performance of 68Ga-Labeled Prostate-Specific Membrane Antigen and 18F-Choline PET/CT in Prostate Cancer: A Systematic Review and Meta-analysis.
Lin CY; Lee MT; Lin CL; Kao CH
Clin Nucl Med; 2019 May; 44(5):365-376. PubMed ID: 30888999
[TBL] [Abstract][Full Text] [Related]
8. Metastatic poorly differentiated prostatic carcinoma with neuroendocrine differentiation: negative on 68Ga-PSMA PET/CT.
Chakraborty PS; Tripathi M; Agarwal KK; Kumar R; Vijay MK; Bal C
Clin Nucl Med; 2015 Feb; 40(2):e163-6. PubMed ID: 25275415
[TBL] [Abstract][Full Text] [Related]
9. Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer?
Raju S; Sharma A; Patel C; Sahoo R; Das CJ; Kumar S; Sharma A; Kumar R
Nucl Med Commun; 2020 Nov; 41(11):1183-1188. PubMed ID: 32796451
[TBL] [Abstract][Full Text] [Related]
10. Non-Prostate-Specific Membrane Antigen-Avid Metastatic Lung Nodule From Primary Prostatic Adenocarcinoma.
Shetty D; Loh H; Bui C; Mansberg R; Hadjashrafi A; Do V
Clin Nucl Med; 2016 Oct; 41(10):776-8. PubMed ID: 27556788
[TBL] [Abstract][Full Text] [Related]
11. Incidental Meningioma Mimicking Metastasis of Prostate Adenocarcinoma in 68Ga-Labeled PSMA Ligand PET/CT.
Bilgin R; Ergül N; Çermik TF
Clin Nucl Med; 2016 Dec; 41(12):956-958. PubMed ID: 27824323
[TBL] [Abstract][Full Text] [Related]
12. 68Ga-PSMA-11 PET/CT in Newly Diagnosed Prostate Adenocarcinoma.
Ergül N; Yilmaz Güneş B; Yücetaş U; Toktaş MG; Çermik TF
Clin Nucl Med; 2018 Dec; 43(12):e422-e427. PubMed ID: 30273204
[TBL] [Abstract][Full Text] [Related]
13. Intertumoral Heterogeneity of 18F-FDG and 68Ga-PSMA Uptake in Prostate Cancer Pulmonary Metastases.
Perez PM; Hope TA; Behr SC; van Zante A; Small EJ; Flavell RR
Clin Nucl Med; 2019 Jan; 44(1):e28-e32. PubMed ID: 30394930
[TBL] [Abstract][Full Text] [Related]
14. Prostate-Specific Membrane Antigen PET/CT Findings for Hepatic Hemangioma.
Bhardwaj H; Stephens M; Bhatt M; Thomas PA
Clin Nucl Med; 2016 Dec; 41(12):968-969. PubMed ID: 27749413
[TBL] [Abstract][Full Text] [Related]
15. PET radiotracers for whole-body in vivo molecular imaging of prostatic neuroendocrine malignancies.
Cohen D; Hazut Krauthammer S; Fahoum I; Kesler M; Even-Sapir E
Eur Radiol; 2023 Sep; 33(9):6502-6512. PubMed ID: 37052659
[TBL] [Abstract][Full Text] [Related]
16. 68Ga-PSMA Uptake by Dermatofibroma in a Patient With Prostate Cancer.
Aydin F; Akçal A; Ünal B; Sezgin Göksu S; Güngör F
Clin Nucl Med; 2017 May; 42(5):358-360. PubMed ID: 28240656
[TBL] [Abstract][Full Text] [Related]
17. Loss of PSMA Expression in Non-neuroendocrine Dedifferentiated Acinar Prostate Cancer.
Bronsert P; Reichel K; Ruf J
Clin Nucl Med; 2018 Jul; 43(7):526-528. PubMed ID: 29659395
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors.
Zhou Z; Wang Z; Zhang B; Wu Y; Li G; Wang Z
Front Endocrinol (Lausanne); 2021; 12():727327. PubMed ID: 34539577
[TBL] [Abstract][Full Text] [Related]
19. Different Appearances of 3 Malignancies in 68Ga-PSMA-11 Versus 18F-FDG PET/CT.
Weitzer F; Nazerani-Hooshmand T; Aigner RM; Pernthaler B
Clin Nucl Med; 2021 Jul; 46(7):e358-e359. PubMed ID: 34081054
[TBL] [Abstract][Full Text] [Related]
20. Early dynamic imaging in
Uprimny C; Kroiss AS; Decristoforo C; Fritz J; Warwitz B; Scarpa L; Roig LG; Kendler D; von Guggenberg E; Bektic J; Horninger W; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2017 May; 44(5):765-775. PubMed ID: 27900519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
